Isomalyngamide A, A-1 and their analogs suppress cancer cell migration in vitro

European Journal of Medicinal Chemistry

Volumn 46, Issue 9, 2011, Pages 3810-3819

  Chang, Tzu Ting ^a   More, Shivaji V ^a   Lu, I Hsuan ^a   Hsu, Jui Ching ^a   Chen, Ting Ju ^b   Jen, Ya Ching ^a   Lu, Chung Kuang ^b   Li, Wen Shan ^a  

^a INSTITUTE OF CHEMISTRY   (Taiwan)

^b NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

Author keywords

Antimetastatic agents; Cancer cell migration; Integrin signaling; Isomalyngamide; Marine metabolites; Sialyltransferase inhibitor

Indexed keywords

1 ACETYL 4 METHOXY 1H PYRROL 2(5H)ONE; 2 [2,2 DIMETHYL 3 OXO 3 (2 TETRADECANAMIDOETHYLAMINO)PROPANAMIDO]ACETIC ACID; 2,2,5,5 TETRAMETHYL 1,3 DIOXANE 4,6 DIONE; 3 (2 TERT BUTOXY 2 OXOETHYLAMINO) 2,2 DIMETHYL 3 OXOPROPANOIC ACID; 4 METHOXY 1 TETRADECANOYL 1H PYRROL 2(5H)ONE; ANTINEOPLASTIC AGENT; BETA1 INTEGRIN; FOCAL ADHESION KINASE; ISOMALYNGAMIDE A; ISOMALYNGAMIDE A 1; ISOMALYNGAMIDE A DERIVATIVE; METHYL 3 (4 METHOXY 2 OXO 2,5 DIHYDRO 1H PYRROL 1 YL) 3 OXOPROPANOATE; N (2 AMINOETHYL)PIVALAMIDE; N (2 AMINOETHYL)TETRADECANAMIDE; N [2 [3 (2,4 DIOXOPYRROLIDIN 1 YL) 2,2 DIMETHYL 3 OXOPROPANAMIDO]ETHYL]TETRA DECANAMIDE; PROTEIN KINASE B; TERT BUTYL 2 [2,2 DIMETHYL 3 OXO 3 (2 TETRADECANAMIDOETHYLAMINO)PROPANAMIDO]ACETATE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL MIGRATION; CELL VIABILITY; DRUG ISOLATION; DRUG STRUCTURE; FEMALE; GENE EXPRESSION; GENE INACTIVATION; HUMAN; HUMAN CELL; IC 50; METASTASIS INHIBITION; WOUND HEALING;

AMIDES; ANTIGENS, CD29; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASM METASTASIS; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; PYRROLES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT; SPECTROPHOTOMETRY, INFRARED;

EID: 80052917694     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2011.05.049     Document Type: Article

References (48)

1. I. Mancini, G. Guella, and A. Defant Synthesis of marine natural products with antimalarial activity Mini-Rev. Med. Chem. 8 2008 1265 1284
2. D. Laurent, and F. Pietra Antiplasmodial marine natural products in the perspective of current chemotherapy and prevention of malaria: a review Mar Biotechnol. 8 2006 433 447
3. J.P. Davidson, and E.J. Corey First enantiospecific total synthesis of the antitubercular marine natural product pseudopteroxazole. Revision of assigned stereochemistry J. Am. Chem. Soc. 125 2003 13486 13489
4. K.A. El Sayed, P. Bartyzel, X. Shen, T.L. Perry, J.K. Zjawiony, and M.T. Hamann Marine natural products as antituberculosis agents Tetrahedron 56 2000 949 953
5. W. Xie, D. Ding, W. Zi, G. Li, and D. Ma Total synthesis and structure assignment of papuamide B, A potent marine cyclodepsipeptide with anti-HIV properties Angew. Chem. Int. Ed. 47 2008 2844 2848
6. L. Gupta, A. Talwar, and P.M. Chauhan Bis and tris indole alkaloids from marine organisms: new leads for drug discovery Curr. Med. Chem. 14 2007 1789 1803
7. L.A. Tziveleka, C. Vagias, and V. Roussis Natural products with anti-HIV activity from marine organisms Curr. Top. Med. Chem. 3 2003 1512 1535
8. T.A. Gulder, and B.S. Moore Chasing the treasures of the sea-bacterial marine natural products Curr. Opin. Microbiol. 12 2009 252 260
9. T.F. Molinski, D.S. Dalisay, S.L. Lievens, and J.P. Saludes Drug development from marine natural products Nat. Rev. Drug Discov. 8 2009 69 85
10. H. Fan, J. Peng, M.T. Hamann, and J.F. Hu Lamellarins and related pyrrole-derived alkaloids from marine organisms Chem. Rev. 108 2008 264 284
11. Y. Kimura Bioactive natural products (Part N) A. Rahman, In the Studies in Natural Products Chemistry 34 2008 Elsevier Science Ltd. Amsterdam 35 76
12. L. Perez, and S.J. Danishefsky Chemistry and biology in search of antimetastatic agents ACS Chem. Biol. 20 2007 159 162
13. L. Chen, S. Yang, J. Jakoncic, J.J. Zhang, and X.Y. Huang Migrastatin analogues target fascin to block tumor metastasis Nature 464 2010 1062 1066
14. T. Oskarsson, P. Nagorny, I.J. Krauss, L. Perez, M. Mandal, G. Yang, O. Ouerfelli, D. Xiao, M.A. Moore, J. Massagué, and S.J. Danishefsky Diverted total synthesis leads to the generation of promising cell-migration inhibitors for treatment of tumor metastasis: in vivo and mechanistic studies on the migrastatin core ether analog J. Am. Chem. Soc. 132 2010 3224 3228
15. J. Ju, S.R. Rajski, S.K. Lim, J.W. Seo, N.R. Peters, F.M. Hoffmann, and B. Shen Lactimidomycin, iso-migrastatin and related glutarimide-containing 12-membered macrolides are extremely potent inhibitors of cell migration J. Am. Chem. Soc. 131 2009 1370 1371
16. J. Ju, S.R. Rajski, S.K. Lim, J.W. Seo, N.R. Peters, F.M. Hoffmann, and B. Shen Evaluation of new migrastatin and dorrigocin congeners unveils cell migration inhibitors with dramatically improved potency Bioorg. Med. Chem. Lett. 18 2008 5951 5954
17. B.B. Metaferia, L. Chen, H.L. Baker, X.Y. Huang, and C.A. Bewley Synthetic macrolides that inhibit breast cancer cell migration in vitro J. Am. Chem. Soc. 129 2007 2434 2435
18. D. Shan, L. Chen, J.T. Njardarson, C. Gaul, X. Ma, S.J. Danishefsky, and X.Y. Huang Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice Proc. Natl. Acad. Sci. USA 102 2005 3772 3776
19. J.T. Njardarson, C. Gaul, D. Shan, X.Y. Huang, and S.J. Danishefsky Discovery of potent cell migration inhibitors through total synthesis: lessons from structure-activity studies of (+)-migrastatin J. Am. Chem. Soc. 126 2004 1038 1040
20. S.A. Scott, P.E. Selvy, J.R. Buck, H.P. Cho, T.L. Criswell, A.L. Thomas, M.D. Armstrong, C.L. Arteaga, C.W. Lindsley, and H.A. Brown Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness Nat. Chem. Biol. 5 2009 108 117
21. I.T. Lim, S.O. Meroueh, M. Lee, M.J. Heeg, and S. Mobashery Strategy in inhibition of cathepsin B, A target in tumor invasion and metastasis J. Am. Chem. Soc. 126 2004 10271 10277
22. P.S. Steeg Tumor metastasis: mechanistic insights and clinical challenges Nat. Med. 12 2006 895 904
23. P.S. Steeg, and D. Theodorescu Metastasis: a therapeutic target for cancer Nat. Clin. Pract. Oncol. 5 2008 206 219
24. J.H. Cardellina II, F.J. Marner, and R.E. Moore Malyngamide A, a novel chlorinated metabolite of the marine cyanophyte Lyngbya majuscule J. Am. Chem. Soc. 101 1979 240 242
25. Y. Kan, B. Sakamoto, T. Fujita, and H. Nagai New malyngamides from the Hawaiian cyanobacterium Lyngbya majuscule J. Nat. Prod. 63 2000 1599 1602
26. Y. Li, J.P. Feng, W.H. Wang, J. Chen, and X.P. Cao Total synthesis and correct absolute configuration of malyngamide U J. Org. Chem. 72 2007 2344 2350
27. J. Chen, X.G. Fu, L. Zhou, J.T. Zhang, X.L. Qi, and X.P. Cao A convergent route for the total synthesis of malyngamides O, P, Q, and R J. Org. Chem. 74 2009 4149 4157
28. J.S. Todd, and W.H. Gerwick Malyngamide I and the structure revision of stylocheilamide Tetrahedron Lett. 36 1995 7837 7840
29. Y. Kan, T. Fujita, H. Nagai, B. Sakamoto, and Y. Hokama Malyngamides M and N from the hawaiian red alga Gracilaria coronopifolia J. Nat. Prod. 61 1998 152 155
30. W.A. Gallimore, and P.J. Scheuer Malyngamides O and P from the sea hare Stylocheilus longicauda J. Nat. Prod. 63 2000 1422 1424
31. K.E. Milligan, B. Marquez, T. Williamson, M. Davies-Coleman, and W.H. Gerwick Two new malyngamides from a madagascan Lyngbya majuscule J. Nat. Prod. 63 2000 965 968
32. J.H. Cardellina II, D. Dalietos, F.J. Marner, J.S. Mynderse, and R.E. Moore (-)-trans-7(S)-Methoxytetradec-4-enoic acid and related amides from the marine cyanophyte Lyngbya majuscule Phytochemistry 17 1978 2091 2095
33. A.J. Ridley, M.A. Schwartz, K. Burridge, R.A. Firtel, M.H. Ginsberg, G. Borisy, J.T. Parsons, and A.R. Horwitz Cell migration: integrating signals from front to back Science 302 2003 1704 1709
34. W. Guo, and F.G. Giancotti Integrin signalling during tumour progression Nat. Rev. Mol. Cell. Biol. 5 2004 816 826
35. Y.A. Choi, D.K. Kim, S.S. Kang, J.K. Sonn, and E.J. Jin Integrin signaling and cell spreading alterations by rottlerin treatment of chick limb bud mesenchymal cells Biochimie 91 2009 624 631
36. W. Brenner, I. Greber, J. Gudejko-Thiel, S. Beitz, E. Schneider, S. Walenta, K. Peters, R. Unger, and J.W. Thüroff Migration of renal carcinoma cells is dependent on protein kinase Cdelta via beta1 integrin and focal adhesion kinase Int. J. Oncol. 32 2008 1125 1131
37. J. Zhao, and J.L. Guan Signal transduction by focal adhesion kinase in cancer Cancer Metastasis Rev. 28 2009 35 49
38. T. Shibue, and R.A. Weinberg Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs Proc. Natl. Acad. Sci. USA 106 2009 10290 10295
39. Q. Huang, H.M. Shen, G. Shui, M.R. Wenk, and C.N. Ong Emodin inhibits tumor cell adhesion through disruption of the membrane lipid rafts-associated integrin signaling pathway Cancer Res. 66 2006 5807 5815
40. D.H. Dube, and C.R. Bertozzi Glycans in cancer and inflammation - potential for therapeutics and diagnostics Nat. Rev. Drug Discov. 4 2005 477 488
41. G. Yogeeswaran, and P.L. Salk Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines Science 212 1981 1514 1516
42. E.C. Seales, G.A. Jurado, B.A. Brunson, J.K. Wakefield, A.R. Frost, and S.L. Bellis Hypersialylation of B1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility Cancer Res. 65 2005 4645 4652
43. D.R. Christie, F.M. Shaikh, J.A. Lucas IV, J.A. Lucas III, and S.L. Bellis ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function J. Ovarian Res. 1 2008 3
44. M. Hedlund, E. Ng, A. Varki, and N.M. Varki α2-6-linked sialic acids on N-glycans modulate carcinoma differentiation in vivo Cancer Res. 68 2008 388 394
45. J.Y. Chen, Y.A. Tang, S.M. Huang, H.F. Juan, L.W. Wu, Y.C. Sun, S.C. Wang, K.W. Wu, G. Balraj, T.T. Chang, W.S. Li, H. Ch. Cheng, and Y.C. Wang A novel sialyltransferase inhibitor suppresses FAK/Paxillin signaling and cancer angiogenesis and metastasis pathways Cancer Res. 71 2011 473 483
46. C.H. Chiang, C.H. Wang, H.C. Chang, S.V. More, W.S. Li, and W.C. Hung A novel sialyltransferase inhibitor AL10 suppresses invasion and metastasis of lung cancer cells by inhibiting integrin-mediated signaling J. Cell. Physiol. 223 2010 492 499
47. K.H. Chang, L. Lee, J. Chen, and W.S. Li Lithocholic acid analogues, new and potent α-2,3-sialyltransferase inhibitors Chem. Commun. 2006 629 631
48. K. Inami, and T. Shiba Total synthesis of antibiotic althiomycin Bull. Chem. Soc. Jpn. 58 1985 352 360